This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chandran, K.
Right arrow Articles by Nibert, M. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chandran, K.
Right arrow Articles by Nibert, M. L.

 Previous Article  |  Next Article 

Journal of Virology, June 2001, p. 5335-5342, Vol. 75, No. 11
0022-538X/01/$04.00+0   DOI: 10.1128/JVI.75.11.5335-5342.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.

Complete In Vitro Assembly of the Reovirus Outer Capsid Produces Highly Infectious Particles Suitable for Genetic Studies of the Receptor-Binding Protein

Kartik Chandran,1,dagger Xing Zhang,2 Norman H. Olson,2 Stephen B. Walker,2 James D. Chappell,3 Terence S. Dermody,3 Timothy S. Baker,2 and Max L. Nibert1,*

Department of Biochemistry and Institute for Molecular Virology, University of Wisconsin---Madison, Madison, Wisconsin 537061; Department of Biological Sciences, Purdue University, West Lafayette, Indiana 479072; and Departments of Pediatrics and Microbiology and Immunology and Elizabeth B. Lamb Center for Pediatric Research, Vanderbilt University School of Medicine, Nashville, Tennessee 372323

Received 15 November 2000/Accepted 7 March 2001


    ABSTRACT
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References

Mammalian reoviruses, prototype members of the Reoviridae family of nonenveloped double-stranded RNA viruses, use at least three proteins---sigma 1, µ1, and sigma 3---to enter host cells. sigma 1, a major determinant of cell tropism, mediates viral attachment to cellular receptors. Studies of sigma 1 functions in reovirus entry have been restricted by the lack of methodologies to produce infectious virions containing engineered mutations in viral proteins. To mitigate this problem, we produced virion-like particles by "recoating" genome-containing core particles that lacked sigma 1, µ1, and sigma 3 with recombinant forms of these proteins in vitro. Image reconstructions from cryoelectron micrographs of the recoated particles revealed that they closely resembled native virions in three-dimensional structure, including features attributable to sigma 1. The recoated particles bound to and infected cultured cells in a sigma 1-dependent manner and were approximately 1 million times as infectious as cores and 0.5 times as infectious as native virions. Experiments with recoated particles containing recombinant sigma 1 from either of two different reovirus strains confirmed that differences in cell attachment and infectivity previously observed between those strains are determined by the sigma 1 protein. Additional experiments showed that recoated particles containing sigma 1 proteins with engineered mutations can be used to analyze the effects of such mutations on the roles of particle-bound sigma 1 in infection. The results demonstrate a powerful new system for molecular genetic dissections of sigma 1 with respect to its structure, assembly into particles, and roles in entry.


    INTRODUCTION
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References

Mammalian orthoreoviruses (reoviruses) provide useful models to study how viruses from the Reoviridae family in particular, and viruses lacking lipid envelopes in general, enter their host cells and initiate infection. Reovirus virions are 85-nm particles comprising the segmented double-stranded RNA genome enclosed by two concentric icosahedral protein capsids. The outer capsid mediates viral entry into the cytoplasm of host cells, where viral replication occurs. Outer capsid protein sigma 1 (50 kDa, 36 copies) forms trimers that extend from the fivefold axes of virions and mediates viral attachment to cellular receptors. µ1 (76 kDa, 600 copies), found in virions mostly as fragments µ1N (4 kDa) and µ1C (72 kDa), participates in viral penetration of the cellular membrane barrier during entry. sigma 3 (41 kDa, 600 copies), the major surface protein of virions, interacts closely with µ1, thereby controlling its conformational status. lambda 2 (144 kDa, 60 copies) forms pentameric turrets that surround the fivefold axes and bridge the inner and outer capsids. lambda 2 is involved in viral mRNA synthesis and assembly of the outer capsid onto virus particles but is not known to participate in entry. Several recent articles discuss the structure of reovirus virions and functions ascribed to the capsid proteins (30, 34, 48).

Reovirus entry into cells is a multistep process characterized by programmed disassembly of virions into at least two types of subvirion particles, each with specialized roles in infection (28, 34, 48). After binding to a receptor(s) at the cell surface, virions are taken up into the endocytic pathway. There, lysosomal proteinases act upon them to produce intermediates that resemble infectious subvirion particles (ISVPs) generated by in vitro proteinase treatment of virions (2, 14, 42). ISVPs lack sigma 3, contain a cleaved form of µ1C, and may possess a conformer of sigma 1 different from that in virions (9, 26, 29, 35, 40). These ISVP-like particles initiate penetration of cellular membranes, culminating in delivery of particles into the cytoplasm (10, 32, 42). Concomitantly with membrane penetration, virus particles are activated to synthesize the viral mRNAs. These transcriptase particles may resemble cores produced by in vitro proteinase treatment of virions or ISVPs (11, 28, 40). Cores lack µ1 and sigma 1, contain a conformer of lambda 2 different from that present in virions and ISVPs, and are transcriptionally active (11, 21, 29, 40).

The mechanisms by which outer capsid proteins sigma 1, µ1, and sigma 3 mediate the steps in viral entry remain to be fully elucidated. A major obstacle is the lack of a reverse genetics system to produce virions with mutations in these proteins. To mitigate this problem, we recently described a strategy termed "recoating genetics" that permits analysis of infectious particles containing engineered forms of µ1 and sigma 3 (12, 27). Recoating genetics is enabled by the capacity of the recombinant proteins to bind and "recoat" purified subvirion particles in vitro, generating infectious particles that resemble virions: sigma 3 binds ISVPs to produce recoated ISVPs, and µ1 and sigma 3 bind cores to produce recoated cores (r-cores). However, recoated ISVPs and r-cores do not permit molecular genetic studies of the receptor-binding protein sigma 1 because the former particles contain native sigma 1 and the latter particles lack sigma 1 altogether. In this report, we extend recoating genetics to the sigma 1 protein by generating a new type of recoated cores that contains recombinant sigma 1, µ1, and sigma 3 (r-cores+sigma 1). These particles closely resemble native virions in structure, behavior in entry assays, and infectivity in cultured cells. Experiments with r-cores+sigma 1 demonstrated their utility for molecular genetic studies of sigma 1 and provided new insights into the structure and assembly of reovirus particles.


    MATERIALS AND METHODS
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References

Cells and viruses. Spinner-adapted murine L929 fibroblast cells (L cells) (26), murine erythroleukemia cells (MEL cells) (39), Spodoptera frugiperda Sf21 insect cells (12), and Trichoplusia ni Tn High Five insect cells (Invitrogen) (12) were grown as described previously. Purified reovirus virions (26), ISVPs (26), and cores (12) were obtained as described previously. Particle concentrations were measured by A260 (19, 41). Plaque assays to determine infectivities of reovirus preparations were performed as described previously (26). cDNA clones and recombinant baculoviruses for expressing µ1 and sigma 3 together (12) or sigma 1 alone (15, 22) have been described previously.

Expression of sigma 1, µ1, and sigma 3. Tn High Five cells were infected with fourth-passage virus stocks at a multiplicity of infection of 5 to 10 PFU/cell, and cells were harvested at 65 h postinfection. Cytoplasmic lysates of baculovirus-infected cells expressing µ1 and sigma 3 only were prepared by lysis with Triton X-100 as described previously (12). Lysates containing sigma 1, µ1, and sigma 3 were generated as follows: cells were separately infected with sigma 1- and µ1/sigma 3-expressing baculoviruses (1.5 × 107 cells each), mixed together, resuspended in 1 ml of lysis buffer (100 mM NaCl, 1.5 mM MgCl2, 250 mM sucrose, 10 mM Tris [pH 7.5]), lysed by probe sonication in an ice-ethanol bath (six 25-s pulses at 15 W), and centrifuged at 14,000 × g for 10 min at 4°C. The supernatant was used to prepare r-cores+sigma 1. Cells were separately infected with the sigma 1- and µ1/sigma 3-expressing baculoviruses because coinfection substantially reduced the yield of each protein at the multiplicity of infection used.

Preparation of r-cores, r-cores+sigma 1, and proteinase-treated r-cores+sigma 1. r-cores were prepared from insect cell lysates containing µ1 and sigma 3 essentially as described previously (12). Briefly, lysates were incubated with purified T1L cores at a ratio of 6 × 106 cell equivalents (400 µl of lysate) per 1012 cores at 37°C for 2 h. The amounts of µ1 (200 µg) and sigma 3 (100 µg) present in the lysate represented a twofold excess of protein relative to the amounts needed to fully recoat the cores. Reaction mixtures were chilled and then loaded atop 14-ml step gradients, each containing a preformed CsCl gradient (rho  = 1.25 to 1.55 g/cm3, 12 ml) and a 2-ml sucrose cushion (20% [wt/vol]). Gradients were centrifuged for 2 to 16 h in a Beckman SW-28 rotor at 25,000 rpm and 5°C. r-cores were recovered as an optically homogeneous band and were further purified by being loaded onto a preformed CsCl gradient (rho  = 1.25 to 1.45 g/cm3, 4 ml) and centrifuged overnight in a Beckman SW-50.1 rotor at 40,000 rpm and 5°C. The harvested particles were dialyzed extensively against virion buffer. r-cores+sigma 1 were prepared in the same way as were r-cores, except that lysates containing sigma 1, µ1, and sigma 3 were used at a ratio of 1.2 × 107 cell equivalents (400 µl of lysate) per 1012 cores. The amount of sigma 1 (5 mg) present in the lysate represented a 500-fold excess of protein relative to the amount needed to fully recoat the cores. Concentrations of r-cores and r-cores+sigma 1 were measured by densitometry of Coomassie blue-stained gels as described previously (12). Proteinase-treated r-cores+sigma 1 were prepared from r-cores+sigma 1 by in vitro treatment with chymotrypsin as described previously (12).

Cryo-TEM and image reconstructions. Purified virions and r-cores+sigma 1 were embedded in vitreous ice, and micrographs were captured at a nominal magnification of 38,000× using low-dose transmission cryoelectron microscopy (cryo-TEM) procedures (4) on a Philips CM200FEG microscope. Micrographs were digitized at a 7-µm step size on a Zeiss PHODIS microdensitometer. Image pixels were bin averaged to obtain pixel sizes of 14 µm (3.68 Å) for virions and r-cores+sigma 1 and 21 µm (5.53 Å) for r-cores. The r-core data were obtained from previously captured micrographs (12), except that 194 instead of 228 particles were used and these were reprocessed to reduce the effects of the microscope contrast transfer function in the final density maps. The r-core+sigma 1 data consisted of 1,078 particles (eight micrographs; defocus values, 1.4- to 2.5-µm underfocus). The virion data consisted of 860 particles (five micrographs; defocus values, 1.4- to 2.8-µm underfocus). Reconstructions were computed using established icosahedral particle procedures (6, 25). Corrections to compensate in part for the effects of the microscope contrast transfer function were applied to image data in the reconstruction program with Wiener filtering as described previously (49). For all three particle types, orientation angles were evenly distributed throughout the asymmetric unit as shown by all inverse eigenvalues being <0.1 (25). Final density maps were calculated to a 24-Å resolution limit, deemed to be near or below the resolution of each of the data sets as measured by various R-factor, correlation coefficient, and phase difference calculations (5). For the r-core+sigma 1 minus r-core difference map (21, 47), the magnifications and density values of the maps were scaled for maximum correlation of densities between radii 220 and 450 Å. The scaled r-core map was then subtracted from the r-core+sigma 1 map and displayed at a density threshold approximately three times higher than that used for the other maps, thereby allowing visualization of the most significant portions of the difference map.


    RESULTS
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References

In vitro recoating of cores with recombinant sigma 1, µ1, and sigma 3 proteins. To test whether recombinant sigma 1 can be added to cores in vitro along with µ1 and sigma 3, a cell lysate containing all three proteins was incubated with purified cores, and virus particles were repurified by CsCl gradient centrifugation. Gel electrophoresis revealed that proteins comigrating with sigma 1, µ1 and µ1C (henceforth termed µ1/µ1C), and sigma 3 had bound to cores (Fig. 1). The identities of these proteins were confirmed by immunoblotting with polypeptide-specific antibodies (data not shown). No other proteins from the cell lysate were detected in the recoated particles. The cores recoated with sigma 1, µ1/µ1C, and sigma 3 (r-cores+sigma 1) in this study contained approximately stoichiometric amounts of µ1/µ1C and sigma 3 relative to virions (data not shown), as previously shown for cores recoated with only µ1/µ1C and sigma 3 (r-cores) (12). The amount of sigma 1 in r-cores+sigma 1 varied between preparations but was always sufficient to be detected by Coomassie blue staining. In several preparations of r-cores+sigma 1, the amount of sigma 1 approached that in virions (Fig. 1), suggesting that sigma 1 can bind to cores in vitro with approximately native stoichiometry.


View larger version (39K):
[in this window]
[in a new window]
 
FIG. 1.   Protein composition of r-cores+sigma 1. Purified virions, cores, r-cores, and two preparations of r-cores+sigma 1 (no. 1 and no. 2) (8 × 1010 particles each) were subjected to sodium dodecyl sulfate-polyacrylamide gel electrophoresis (10% acrylamide) and Coomassie blue staining. Positions of viral proteins are indicated at left, and the position of sigma 1 is highlighted with arrows.

r-cores+sigma 1 resemble virions in structure. Comparison of the image reconstruction of r-cores+sigma 1 with those of virions and r-cores revealed that all three types of particles are similar in overall appearance. Each possesses 600 finger-like projections at the particle surface attributed to the 600 subunits of sigma 3, features beneath the sigma 3 layer that represent the 600 subunits of µ1, and similar conformational states of the pentameric lambda 2 turret (Fig. 2a to c). Image reconstructions of virions (Fig. 2a) and r-cores+sigma 1 (Fig. 2c) also contain an extended feature emerging from the center of the lambda 2 turret that, in virions and ISVPs, has been attributed to sigma 1 (21). The presence of this feature in r-cores+sigma 1 and its absence in r-cores (Fig. 2b) support the conclusion that r-cores+sigma 1, like virions, contain sigma 1 bound at the fivefold axes.


View larger version (54K):
[in this window]
[in a new window]
 
FIG. 2.   Image reconstruction of r-cores+sigma 1. (a to c) Composite images comprising external (left half) and cutaway (right half) surface-shaded representations of virions (a), r-cores (b), and r-cores+sigma 1 (c) are shown. Features attributed to outer capsid proteins and the genome are labeled in panel a. (d) Difference map between r-cores+sigma 1 and r-cores. Only density features in the front half of the map are shown and are coded in red. (e) The difference map (red) superimposed upon a cutaway section of the r-core map. Features in the difference map at positions above and below the sectioning plane are not shown. (f) Magnified view of a portion of the image in panel e. One segment of the pentameric shutter that closes the lambda 2 turret is labeled (*). Scale bar, 200 Å.

A feature attributable to sigma 1 is present within the lambda 2 turret. Difference maps between the r-core+sigma 1 and r-core reconstructions were computed to assess more carefully the effects of sigma 1 assembly on particle structure (Fig. 2d). Only two significant density features, both located at the fivefold axes of r-cores+sigma 1, were seen in the difference map. The absence of significant differences in other locations confirmed that assembly of sigma 1 into r-cores+sigma 1 causes no major rearrangements in the core proteins, µ1, sigma 3, or regions of lambda 2 distal from sigma 1. Superposition of the two features upon a cutaway section of the r-core reconstruction (Fig. 2e and f) indicated that the upper feature represents the sigma 1 fiber extending above lambda 2 (see above). The lower feature is located in line with the upper feature, just beneath the pentameric "shutter" that closes the top of the lambda 2 turret. This feature might represent either a portion of sigma 1 or fivefold-proximal lambda 2 sequences that have undergone rearrangement upon sigma 1 binding. However, we consider the latter unlikely because all of the density associated with lambda 2 in r-cores is also present at similar positions in r-cores+sigma 1 (i.e., no significant loss of density from the lambda 2 region was seen in the inverse difference map of the r-core and r-core+sigma 1 reconstructions [data not shown]). Therefore, we conclude that this lower feature represents the base of the sigma 1 fiber that protrudes through the lambda 2 shutter and into the turret cavity.

r-cores+sigma 1 bind efficiently to RBCs and L cells. To assess the competence of recombinant sigma 1 in r-cores+sigma 1 for binding to cell receptors, we measured the capacity of virions, cores, r-cores, and r-cores+sigma 1 to induce hemagglutination (HA) of human erythrocytes (RBCs) (Fig. 3a). sigma 1 mediates HA via its interactions with one or more glycoprotein on the cell surface (1, 38). Virions induced HA efficiently as expected, while cores and r-cores, which lack sigma 1, failed to do so even at the highest particle concentration tested (fivefold higher than the maximum shown in Fig. 3a [data not shown]). r-cores+sigma 1 agglutinated RBCs nearly as efficiently as did virions, indicating that these particles containing recombinant sigma 1 are functional for attachment to the reovirus receptor(s) on human RBCs.


View larger version (51K):
[in this window]
[in a new window]
 
FIG. 3.   Capacity of r-cores+sigma 1 to bind to cells. (a) HA induced by purified virions, cores, r-cores, and r-cores+sigma 1 was determined by endpoint titration using human type A+ RBCs (American Red Cross), as described previously (20). Serial twofold virus dilutions were incubated with RBCs (0.4% [vol/vol]) in a 96-well round-bottomed plate at 4°C for 2 h, and HA was visually detected. The number of HA units induced by a virus preparation is given by the highest number of particles used (2 × 1010 particles) divided by the minimum number of particles required to induce HA. HA activity is expressed as the log2(HA units). Averages ± standard deviations of three replicates are shown. (b) Attachment of purified virions, r-cores, and r-cores+sigma 1 to L cells at 4°C was determined by indirect immunofluorescence as described previously (18). Cells on coverslips were incubated with purified virus (5 × 105 particles/cell) at 4°C for 1 h. Unbound virus was removed by washing with ice-cold phosphate-buffered saline. After the cells were fixed and permeabilized, bound virus was detected by using a 1:500 dilution of rabbit antireovirus serum (44) as primary antibody and a 1:100 dilution of fluorescein isothiocyanate-conjugated donkey anti-rabbit immunoglobulin G (Pierce) as secondary antibody.

We also used indirect immunofluorescence to detect binding of virions, r-cores, and r-cores+sigma 1 to L cells, which are permissive for reovirus infection (Fig. 3b). We found that binding of r-cores to cells, while detectable, was much less efficient than the binding of virions, consistent with the absence of cell attachment protein sigma 1 in r-cores. In contrast, r-cores+sigma 1 bound to L cells with an efficiency similar to that of virions, confirming that the recombinant sigma 1 in r-cores+sigma 1 is functional for efficient attachment to the reovirus receptor(s) expressed in L cells.

r-cores+sigma 1 are nearly as infectious as virions and display similar growth kinetics. r-cores containing levels of µ1/µ1C and sigma 3 similar to those of virions but lacking sigma 1 were 250 to 500 times more infectious in L cells than were precursor cores but only ~0.0001 times as infectious as virions on a per-particle basis (12) (Fig. 4a). r-cores+sigma 1 containing levels of sigma 1 similar to those of virions (Fig. 1) were 3,000 times more infectious than r-cores and 0.5 times as infectious as virions on a per-particle basis (Fig. 4a), consistent with the capacity of r-cores+sigma 1 and virions, but not r-cores, to attach to cells efficiently (Fig. 3b). Infection by virions and r-cores+sigma 1, but not r-cores, was blocked by anti-sigma 1 antibody 5C6 (Fig. 4b) (45), showing that the enhanced infectivity of r-cores+sigma 1 compared with that of r-cores is due to recombinant sigma 1 in the former particles.


View larger version (26K):
[in this window]
[in a new window]
 
FIG. 4.   Infectious properties of r-cores+sigma 1 in L cells. (a) The infectivities of purified virions, cores, r-cores, and r-cores+sigma 1 were determined by plaque assay on L-cell monolayers and expressed as PFU per milliliter (26). After standardization against the number of virus particles per milliliter, the relative infectivity of each preparation was determined by dividing its PFU per milliliter by the PFU of cores per milliliter. Averages of three replicates are shown (standard deviation <=  0.10 log10 units). (b) The capacity of anti-T1L sigma 1 antibody 5C6 to neutralize formation of plaques on L cells by purified virions, r-cores, and r-cores+sigma 1 was determined as described previously (12). Virus (100 PFU) was incubated with 5C6 (1 µg/ml) for 1 h at 37°C, and infectivity was measured by plaque assay. The extent of neutralization for each preparation (expressed as percent plaque survival) was the ratio of PFU obtained in the presence of antibody to the PFU obtained in its absence. Averages ± standard deviations of three replicates are shown. (c) Single-cycle growth curves of purified virions, r-cores+sigma 1, and chymotrypsin treatment mixtures containing ISVPs and proteinase-treated r-cores+sigma 1 (pr-core+sigma 1) (2 PFU/cell) were generated in L cells as described previously (13). Infectivity at a specified time (t) relative to time zero was expressed as log10(PFU/ml)t - log10(PFU/ml)0. Each data point represents the average of duplicate values.

The preceding experiment (Fig. 4a) provided evidence that similar proportions of virions and r-cores+sigma 1, and a much lower proportion of r-cores in preparations of these particles, can initiate infections that result in viral plaques after multiple cycles of replication. To compare the infectious properties of r-cores+sigma 1 and virions during a single replication cycle, we generated growth curves for these particle types (Fig. 4c). Virions and r-cores+sigma 1 showed very similar growth curves, indicating similar kinetics of viral entry and initial production of progeny virus (lag phase), accumulation of progeny (exponential phase), and final growth yields (plateau phase).

ISVPs generated from virions by in vitro proteinase treatment exhibit a shorter lag phase than do virions during a single growth cycle (42) (Fig. 4c). Virions grow more slowly than ISVPs, likely because they contain sigma 3 that must be cleaved within the endocytic pathway before membrane penetration can proceed. ISVPs, on the other hand, already lack sigma 3 and can bypass this step within cells (3, 27, 42). We found that ISVP-like proteinase-treated r-cores+sigma 1 also grew more rapidly than did their virion-like precursors and showed kinetics similar to those of ISVPs. The faster growth of proteinase-treated r-cores+sigma 1 compared with that of r-cores+sigma 1 is consistent with observations that r-cores+sigma 1 must, like virions, undergo sigma 3 degradation in order to initiate infection (data not shown). Thus, r-cores+sigma 1 containing recombinant forms of outer capsid proteins sigma 1, µ1, and sigma 3 reproduce entry-related behaviors observed with native particles.

r-cores+sigma 1 recapitulate strain-dependent differences attributed to sigma 1. Analysis of r-cores+sigma 1 assembled with different types of recombinant sigma 1 provides a new approach for genetic studies of particle-bound forms of this protein. To evaluate the feasibility of this approach, we produced r-core+sigma 1L and r-core+sigma 1D particles containing genome and core, µ1/µ1C, and sigma 3 proteins from reovirus strain type 1 Lang (T1L) but recombinant sigma 1 from strain T1L or type 3 Dearing (T3D), respectively. We then determined the properties of r-cores+sigma 1L and r-cores+sigma 1D in the following assays that show a sigma 1-dependent difference between native T1L and T3D virions.

(i) HA of bovine RBCs (Fig. 5a). T3D virions induce HA of bovine RBCs via interactions between T3D sigma 1 and RBC sialoglycoproteins (20, 38). T1L virions do not agglutinate bovine RBCs, likely because T1L sigma 1 does not bind sialic acid and no other receptors are available for it on these cells (20, 38). r-cores+sigma 1D induced levels of HA similar to those induced by T3D virions, while r-cores+sigma 1L, like T1L virions, failed to induce HA. Thus, the capacity of r-cores+sigma 1 to agglutinate bovine RBCs is determined by the origin of the particle-bound sigma 1 protein, consistent with previous genetic and biochemical evidence (20, 38).


View larger version (24K):
[in this window]
[in a new window]
 
FIG. 5.   Capacity of r-cores+sigma 1 to mediate sigma 1-specific in vitro and in vivo properties. (a) HA of bovine RBCs (Colorado Serum Co.) induced by purified T1L virions, T3D virions, r-cores+sigma 1L, and r-cores+sigma 1D was determined as described for Fig. 3a. Averages ± standard deviations of three replicates are shown. (b) The effect of chymotrypsin treatment on infectivity of T1L virions (open squares), T3D virions (open circles), r-cores+sigma 1L (filled squares), r-cores+sigma 1D (filled circles), and r-cores+sigma 1D(T249I) (filled triangles) was determined as follows. Purified virus (1.5 × 1012 particles/ml) was incubated with chymotrypsin (200 µg/ml) at 37°C. At specified times, an aliquot was removed onto ice and digestion was stopped with phenylmethylsulfonyl fluoride (2 mM). The infectivity of each aliquot was determined by plaque assay. Viral infectivity at a specified time (t) relative to time zero was expressed as described for Fig. 4c. Averages ± standard deviations of three independent experiments are shown. (c) Infectious yields produced in MEL and L cells by T1L virions, T3D virions, r-cores+sigma 1L, and r-cores+sigma 1D were determined as follows. Purified virus (5 PFU/cell) was incubated with 4 × 106 cells for 1 h at room temperature. Unbound virus was removed by centrifugation (500 × g) and washing cells with phosphate-buffered saline. Cells were then resuspended in growth medium and incubated at 37°C for 24 h. Cell lysates were generated by freeze-thawing, and the amount of infectious virus in these lysates was determined by plaque assay. Growth yields were expressed as log10(PFU/ml) at 24 h. Averages ± standard deviations of six trials from two independent experiments are shown.

(ii) Effect of in vitro chymotrypsin treatment on viral infectivity (Fig. 5b). When T1L virions are treated with chymotrypsin in vitro, infectivity increases at early times and is then maintained for at least 2 h. In contrast, the infectivity of T3D virions increases transiently upon chymotrypsin treatment but then decreases to plateau at 10% of the starting value (36). r-cores+sigma 1L and r-cores+sigma 1D behaved like T1L and T3D virions, respectively, upon chymotrypsin treatment, confirming the previous hypothesis (15, 36) that these effects of chymotrypsin on infectivity are determined by the origin of particle-bound sigma 1.

The effects of chymotrypsin treatment on the infectivity of virions and r-cores+sigma 1 correlate with the sensitivity of sigma 1 to cleavage by chymotrypsin (see references 15 and 36 for data for virions; data are not shown for r-cores+sigma 1). Specifically, T1L sigma 1 is not cleaved by chymotrypsin, while T3D sigma 1 is cleaved. This correlation holds true for all other viral strains tested (15). Therefore, the available data suggest a mechanistic link between cleavage of particle-bound sigma 1 and inactivation of infectivity by chymotrypsin treatment. To establish this link, we sought to investigate the infectious behavior of r-cores+sigma 1 generated with a mutant form of T3D sigma 1 engineered to resist cleavage by chymotrypsin. Recent work with isolated sigma 1 proteins suggested a promising candidate: the point mutation T249right-arrowI blocked cleavage of recombinant T3D sigma 1 by trypsin (15). Accordingly, we produced and tested r-cores+sigma 1D(T249I) containing this mutant sigma 1 protein. r-cores+sigma 1D(T249I), in contrast to their wild-type counterparts, retained full infectivity after chymotrypsin treatment (Fig. 5b) while the particle-bound T3D sigma 1(T249I) remained uncleaved (data not shown), proving that the loss of infectivity suffered by T3D virions upon chymotrypsin treatment is caused by cleavage of T3D sigma 1.

(iii) Viral growth in MEL cells (Fig. 5c). T3D virions produce ~10,000 times higher yields of infectious progeny than do T1L virions in MEL cells, whereas the two types produce similar yields in L cells (16, 39). This strain-dependent difference in viral growth has been genetically mapped to the S1 gene segment, which encodes the sigma 1 and sigma 1s proteins (39). Moreover, viral strains adapted to grow in MEL cells contain mutations in sigma 1 that increase their capacity to bind to MEL cells (16). Findings to date therefore support a model in which the capacity of reoviruses to infect and grow in MEL cells is determined by sigma 1-receptor interactions. It remained possible, nevertheless, that the above difference in viral growth arises not from sigma 1 protein present in infecting particles but from sigma 1 transcripts or sigma 1 or sigma 1s polypeptides newly synthesized in infected cells. To test that possibility, we measured the growth yields of r-cores+sigma 1L and r-cores+sigma 1D in MEL and L cells and found that these mirrored the yields obtained with native T1L and T3D virions, respectively. Because r-cores+sigma 1L and r-cores+sigma 1D possessed the same genome (T1L) and differed only in the origin of their particle-bound sigma 1 proteins, our results confirm that the growth difference between T1L and T3D viruses in MEL cells arises from differences in viral entry attributable to particle-bound sigma 1, likely at the cell attachment step.


    DISCUSSION
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References

The sigma 1-lambda 2 interaction in reovirus particles. Protein sigma 1 forms lollipop-shaped homotrimers consisting of a base, a long fibrous tail, a neck, and a globular head (7, 15, 24, 26, 37). The amino-terminal base of sigma 1 anchors it to the particle (26, 31), while more carboxy-terminal sequences in the neck and head domains mediate binding to cellular receptors (16, 20, 23, 33). Image reconstructions of virions and ISVPs show that the base of each sigma 1 fiber is anchored to the particle by interaction with the pentameric shutter atop each lambda 2 turret (21). However, little is known about the structural details of the sigma 1-lambda 2 binding interaction because density features contributed to the binding interface by each protein cannot be distinguished in the cryo-TEM maps of native particles. Comparison of the r-core and r-core+sigma 1 image reconstructions in this report suggests that the base of the sigma 1 fiber protrudes through the center of the pentameric lambda 2 shutter and that these protruding sigma 1 sequences form a small knob-like domain within the large cavity enclosed by the lambda 2 turret. On the basis of this observation, we speculate that the sigma 1 fiber remains anchored to lambda 2 in virions and ISVPs at least in part because its internal knob domain cannot escape through the narrow channel at the center of the lambda 2 shutter in those particles (12, 21). Consistent with that idea, sigma 1 binds poorly to cores (K. Chandran and M. L. Nibert, unpublished data), which contain a larger channel at the center of each open lambda 2 turret (21).

The current observations regarding the mode of sigma 1 binding also have implications for the pathway of sigma 1 assembly into particles. The assembly of µ1 and sigma 3 alone onto cores causes the lambda 2 shutter to close (12). Therefore, if sigma 1 binds to cores after µ1 and sigma 3, the knob-like base of the sigma 1 fiber must be inserted through the narrow fivefold channel in the shutter. Since this seems unlikely, we hypothesize that sigma 1 binds to cores before, or in concert with, µ1 and sigma 3.

Previously published evidence indicates that deletions of residues 3 to 34 or 37 to 107 of T3D sigma 1 block incorporation into virions whereas residues 1 to 121 are sufficient for incorporation (30, 31). However, the specific residues within these regions that mediate binding to lambda 2 remain to be identified. We found that T1L sigma 1 and T3D sigma 1, which share a sequence identity of only 22% within this N-terminal region (37), both bound to T1L cores in a functional manner (Fig. 1 and 5), suggesting that the lambda 2-binding element(s) in sigma 1 is not highly dependent on primary amino acid sequence or that only a few specific residues are involved.

The region(s) of sigma 1 visualized in the cryo-TEM image reconstruction of r-cores+sigma 1. Electron microscopic studies of negatively stained preparations of purified sigma 1 fibers indicate that each is 480 to 500 Å in length, with the N-terminal tail and C-terminal head portions comprising 380 to 400 and 100 Å of the fiber, respectively (24, 26). The density features attributed to sigma 1 in the r-core+sigma 1 reconstruction, however, measure only about 140 Å in length. If the lambda 2-proximal portion of the sigma 1 tail assumes an extended conformation after assembly into r-cores+sigma 1, then the density visualized in the r-core+sigma 1 reconstruction represents only the first 100 to 120 residues of sigma 1 according to the current model for sequence-structure correlations in the fiber (24). This region of the sigma 1 tail comprises the putative N-terminal lambda 2-binding domain and approximately one-half of the long alpha -helical coiled coil (24, 30, 31, 37). More distal tail and head sequences are not visualized in the cryo-TEM map, probably because those regions of the sigma 1 fiber are more variably placed relative to the icosahedral lattice, due to fiber bending. This idea is supported by calculations for position-dependent flexibility of the sigma 1 fiber from electron micrographs as well as from the amino acid sequence: both analyses found a local maximum in fiber flexibility at a distance of about 140 Å along the tail (24). r-cores+sigma 1 containing "stiffened" forms of recombinant sigma 1 may allow visualization of more distal domains in the fiber.

Infectious properties of r-cores+sigma 1. Assembly of approximately stoichiometric amounts of recombinant sigma 1, µ1, and sigma 3 onto cores to produce r-cores+sigma 1 boosted the infectivity of cores by nearly a millionfold, to ~50% of that of virions. This almost complete reconstitution of viral infectivity suggests that r-cores+sigma 1 are free from major defects. Moreover, observations that r-cores+sigma 1 and proteinase-treated r-cores+sigma 1 replicated in L cells with kinetics identical to those of virions and ISVPs, respectively, and that r-cores+sigma 1, like virions, required acid-dependent lysosomal proteinase(s) for infection strongly suggest that these recoated particles utilize the same pathways as do native particles for productive entry. Hence, r-cores+sigma 1 are valid and powerful tools for entry studies.

Utility of r-cores+sigma 1 for genetic studies of sigma 1. Experiments performed with a variety of reovirus strains and cultured cell types indicate that sigma 1 is the primary determinant of cell tropism. The sigma 1-encoding S1 gene segment is also responsible for a number of strain-dependent patterns of viral pathogenesis in infant mice, including the capacity of viruses to infect and replicate in intestinal tissue (see below) and to replicate in neurons in the central nervous system (46). S1 is also a genetic determinant of strain-specific differences in the capacities of reoviruses to induce apoptosis in cultured cells (43). Most, if not all, of these phenotypic differences mapping to S1 may relate to the role of sigma 1 as a receptor-binding protein, suggesting that they should be amenable to analysis with r-cores+sigma 1. In the current study, infections with r-cores+sigma 1 containing T3D or T1L sigma 1 proved that the tropism of T3D, but not T1L, virions for MEL cells is determined by particle-bound sigma 1. Further analysis of this and other phenotypic differences between T1L and T3D viruses by using r-cores+sigma 1 that contain chimeric forms of sigma 1 (17) should aid in dissecting functional domains of this protein.

Results in this study indicate that recoated particles assembled with mutant forms of sigma 1 can be used to pinpoint the molecular basis of a phenotype that is determined by particle-bound sigma 1. Specifically, we showed that the loss of infectivity in cultured cells suffered by T3D virions after chymotrypsin treatment could be reversed by a mutation in the T3D sigma 1 protein that blocked its cleavage by chymotrypsin. These results have implications for viral pathogenesis because the sigma 1 protein of T3D, but not T1L, virions is cleaved by intestinal proteinases (15), and this cleavage pattern correlates with the capacity of T1L, but not T3D, virions to grow to high titers in intestinal tissue following intragastric inoculation (8). Experiments using r-cores+sigma 1 to determine the relationship between sigma 1 cleavage and viral growth in the murine intestine are in progress.

A final point is that r-cores+sigma 1 supersede isolated sigma 1 protein fibers as tools of choice for studies of the structural, biochemical, and functional properties of virion-associated sigma 1. Although isolated sigma 1 fibers recapitulate many properties of the virion-bound protein, including the capacity to bind to cultured cells, the two forms are not indistinguishable. For example, the wild-type T1L sigma 1 and mutant T3D sigma 1(T249I) proteins used in these studies were sensitive to cleavage by chymotrypsin near the base of the fiber in their particle-free form (15, 22) but became resistant to cleavage after incorporation into r-cores+sigma 1 (data not shown), suggesting that this region of sigma 1 undergoes conformational changes upon assembly into particles or is shielded from proteinase by other capsid proteins.


    ACKNOWLEDGMENTS

We thank R. Duncan and P. W. K. Lee for sigma 1-expressing clones and baculoviruses, H. W. Virgin IV and K. L. Tyler for sigma 1 antibody 5C6, and C. M. Contreras for preliminary work on image reconstructions. We thank L. A. Breun and S. J. Harrison for technical support, other members of our laboratories for helpful discussions, and J. Jané-Valbuena and T. J. Broering for reviews of the manuscript.

This work was supported by NIH grants AI39533 (M.L.N.), GM33050 (T.S.B.), and AI38296 (T.S.D.); grants from the Lucille P. Markey Charitable Trust (Wisconsin Institute for Molecular Virology and Purdue Structural Biology Center); DARPA contract MDA 972-97-1-0005 (M.L.N.); and grant P60 DK20593 from the Vanderbilt Diabetes Research and Training Center (T.S.D.). K.C. was also supported by a predoctoral fellowship from the Howard Hughes Medical Institute. T.S.D. was also supported by the Elizabeth B. Lamb Center for Pediatric Research. M.L.N. received additional support as a Shaw Scientist from the Milwaukee Foundation.


    FOOTNOTES

* Corresponding author. Present address: Department of Microbiology and Molecular Genetics, Harvard Medical School, 200 Longwood Ave., Boston, MA 02115. Phone: (617) 432-4829. Fax: (617) 738-7664. E-mail: mnibert{at}hms.harvard.edu.

dagger Present address: Department of Microbiology and Molecular Genetics, Harvard Medical School, Boston, Mass.


    REFERENCES
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References

1. Armstrong, G. D., R. W. Paul, and P. W. K. Lee. 1984. Studies on reovirus receptors of L cells: virus binding characteristics and comparison with reovirus receptors of erythrocytes. Virology 138:37-48[CrossRef][Medline].
2. Baer, G. S., D. H. Ebert, C. J. Chung, A. H. Erickson, and T. S. Dermody. 1999. Mutant cells selected during persistent reovirus infection do not express mature cathepsin L and do not support reovirus disassembly. J. Virol. 73:9532-9543[Abstract/Free Full Text].
3. Baer, G. S., and T. S. Dermody. 1997. Mutations in reovirus outer-capsid protein sigma 3 selected during persistent infections of L cells confer resistance to protease inhibitor E64. J. Virol. 71:4921-4928[Abstract].
4. Baker, T. S., J. Drak, and M. Bina. 1988. Reconstruction of the three-dimensional structure of simian virus 40 and visualization of the chromatin core. Proc. Natl. Acad. Sci. USA 85:422-426[Abstract/Free Full Text].
5. Baker, T. S., N. H. Olson, and S. D. Fuller. 1999. Adding the third dimension to virus life cycles: three-dimensional reconstruction of icosahedral viruses from cryo-electron micrographs. Microbiol. Mol. Biol. Rev. 63:862-922[Abstract/Free Full Text].
6. Baker, T. S., and R. H. Cheng. 1996. A model-based approach for determining orientations of biological macromolecules imaged by cryoelectron microscopy. J. Struct. Biol. 116:120-130[CrossRef][Medline].
7. Bassel-Duby, R., A. Jayasuriya, D. Chatterjee, N. Sonenberg, J. V. Maizel, Jr., and B. N. Fields. 1985. Sequence of reovirus haemagglutinin predicts a coiled-coil structure. Nature 315:421-423[CrossRef][Medline].
8. Bodkin, D. K., and B. N. Fields. 1989. Growth and survival of reovirus in intestinal tissue: role of the L2 and S1 genes. J. Virol. 63:1188-1193[Abstract/Free Full Text].
9. Borsa, J., T. P. Copps, M. D. Sargent, D. G. Long, and J. D. Chapman. 1973. New intermediate subviral particles in the in vitro uncoating of reovirus virions by chymotrypsin. J. Virol. 11:552-564[Abstract/Free Full Text].
10. Borsa, J., B. D. Morash, M. D. Sargent, T. P. Copps, P. A. Lievaart, and J. G. Szekely. 1979. Two modes of entry of reovirus particles into L cells. J. Gen. Virol. 45:161-170[Abstract/Free Full Text].
11. Borsa, J., M. D. Sargent, P. A. Lievaart, and T. P. Copps. 1981. Reovirus: evidence for a second step in the intracellular uncoating and transcriptase activation process. Virology 111:191-200[CrossRef][Medline].
12. Chandran, K., S. B. Walker, Y. Chen, C. M. Contreras, L. A. Schiff, T. S. Baker, and M. L. Nibert. 1999. In vitro recoating of reovirus cores with baculovirus-expressed outer-capsid proteins µ1 and sigma 3. J. Virol. 73:3941-3950[Abstract/Free Full Text].
13. Chandran, K., and M. L. Nibert. 1998. Protease cleavage of reovirus capsid protein µ1/µ1C is blocked by alkyl sulfate detergents, yielding a new type of infectious subvirion particle. J. Virol. 72:467-475[Abstract/Free Full Text].
14. Chang, C. T., and H. J. Zweerink. 1971. Fate of parental reovirus in infected cells. Virology 46:544-555[CrossRef][Medline].
15. Chappell, J. D., E. S. Barton, T. H. Smith, G. S. Baer, D. T. Duong, M. L. Nibert, and T. S. Dermody. 1998. Cleavage susceptibility of reovirus attachment protein sigma 1 during proteolytic disassembly of virions is determined by a sequence polymorphism in the sigma 1 neck. J. Virol. 72:8205-8213[Abstract/Free Full Text].
16. Chappell, J. D., V. L. Gunn, J. D. Wetzel, G. S. Baer, and T. S. Dermody. 1997. Mutations in type 3 reovirus that determine binding to sialic acid are contained in the fibrous tail domain of viral attachment protein sigma 1. J. Virol. 71:1834-1841[Abstract].
17. Chappell, J. D., J. L. Duong, B. W. Wright, and T. S. Dermody. 2000. Identification of carbohydrate-binding domains in the attachment proteins of type 1 and type 3 reoviruses. J. Virol. 74:8472-8479[Abstract/Free Full Text].
18. Compton, T., D. M. Nowlin, and N. R. Cooper. 1993. Initiation of human cytomegalovirus infection requires initial interaction with cell surface heparan sulfate. Virology 193:834-841[CrossRef][Medline].
19. Coombs, K. M. 1998. Stoichiometry of reovirus structural proteins in virus, ISVP, and core particles. Virology 243:218-228[CrossRef][Medline].
20. Dermody, T. S., M. L. Nibert, R. Bassel-Duby, and B. N. Fields. 1990. A sigma 1 region important for hemagglutination by serotype 3 reovirus strains. J. Virol. 64:5173-5176[Abstract/Free Full Text].
21. Dryden, K. A., G. Wang, M. Yeager, M. L. Nibert, K. M. Coombs, D. B. Furlong, B. N. Fields, and T. S. Baker. 1993. Early steps in reovirus infection are associated with dramatic changes in supramolecular structure and protein conformation: analysis of virions and subviral particles by cryoelectron microscopy and image reconstruction. J. Cell Biol. 122:1023-1041[Abstract/Free Full Text].
22. Duncan, R., and P. W. K. Lee. 1994. Localization of two protease-sensitive regions separating distinct domains in the reovirus cell-attachment protein sigma 1. Virology 203:149-152[CrossRef][Medline].
23. Duncan, R., D. Horne, J. E. Strong, G. Leone, R. T. Pon, M. C. Yeung, and P. W. K. Lee. 1991. Conformational and functional analysis of the C-terminal globular head of the reovirus cell attachment protein. Virology 182:810-819[CrossRef][Medline].
24. Fraser, R. D., D. B. Furlong, B. L. Trus, M. L. Nibert, B. N. Fields, and A. C. Steven. 1990. Molecular structure of the cell-attachment protein of reovirus: correlation of computer-processed electron micrographs with sequence-based predictions. J. Virol. 64:2990-3000[Abstract/Free Full Text].
25. Fuller, S. D., S. J. Butcher, R. H. Cheng, and T. S. Baker. 1996. Three-dimensional reconstruction of icosahedral particles---the uncommon line. J. Struct. Biol. 116:48-55[CrossRef][Medline].
26. Furlong, D. B., M. L. Nibert, and B. N. Fields. 1988. sigma 1 protein of mammalian reoviruses extends from the surfaces of viral particles. J. Virol. 62:246-256[Abstract/Free Full Text].
27. Jané-Valbuena, J., M. L. Nibert, S. M. Spencer, S. B. Walker, T. S. Baker, Y. Chen, V. E. Centonze, and L. A. Schiff. 1999. Reovirus virion-like particles obtained by recoating infectious subvirion particles with baculovirus-expressed sigma 3 protein: an approach for analyzing sigma 3 functions during virus entry. J. Virol. 73:2963-2973[Abstract/Free Full Text].
28. Joklik, W. K., and M. R. Roner. 1995. What reassorts when reovirus genome segments reassort? J. Biol. Chem. 270:4181-4184[Free Full Text].
29. Joklik, W. K. 1972. Studies on the effect of chymotrypsin on reovirions. Virology 49:700-715[CrossRef][Medline].
30. Lee, P. W. K., and R. Gilmore. 1998. Reovirus cell attachment protein sigma 1: structure-function relationships and biogenesis. Curr. Top. Microbiol. Immunol. 233:137-153.
31. Leone, G., D. C. Mah, and P. W. K. Lee. 1991. The incorporation of reovirus cell attachment protein sigma 1 into virions requires the N-terminal hydrophobic tail and the adjacent heptad repeat region. Virology 182:346-350[CrossRef][Medline].
32. Lucia-Jandris, P., J. W. Hooper, and B. N. Fields. 1993. Reovirus M2 gene is associated with chromium release from mouse L cells. J. Virol. 67:5339-5345[Abstract/Free Full Text].
33. Nagata, L., S. A. Masri, R. T. Pon, and P. W. K. Lee. 1987. Analysis of functional domains on reovirus cell attachment protein sigma 1 using cloned sigma 1 gene deletion mutants. Virology 160:162-168[CrossRef][Medline].
34. Nibert, M. L. 1998. Structure of mammalian orthoreovirus particles. Curr. Top. Microbiol. Immunol. 233:1-30.
35. Nibert, M. L., and B. N. Fields. 1992. A carboxy-terminal fragment of protein µ1/µ1C is present in infectious subvirion particles of mammalian reoviruses and is proposed to have a role in penetration. J. Virol. 66:6408-6418[Abstract/Free Full Text].
36. Nibert, M. L., J. D. Chappell, and T. S. Dermody. 1995. Infectious subvirion particles of reovirus type 3 Dearing exhibit a loss in infectivity and contain a cleaved sigma 1 protein. J. Virol. 69:5057-5067[Abstract].
37. Nibert, M. L., T. S. Dermody, and B. N. Fields. 1990. Structure of the reovirus cell-attachment protein: a model for the domain organization of sigma 1. J. Virol. 64:2976-2989[Abstract/Free Full Text].
38. Paul, R. W., and P. W. K. Lee. 1987. Glycophorin is the reovirus receptor on human erythrocytes. Virology 159:94-101[CrossRef][Medline].
39. Rubin, D. H., J. D. Wetzel, W. V. Williams, J. A. Cohen, C. Dworkin, and T. S. Dermody. 1992. Binding of type 3 reovirus by a domain of the sigma 1 protein important for hemagglutination leads to infection of murine erythroleukemia cells. J. Clin. Investig. 90:2536-2542.
40. Shatkin, A. J., and A. J. LaFiandra. 1972. Transcription by infectious subviral particles of reovirus. J. Virol. 10:698-706[Abstract/Free Full Text].
41. Smith, R. E., H. J. Zweerink, and W. K. Joklik. 1969. Polypeptide components of virions, top component and cores of reovirus type 3. Virology 39:791-810[CrossRef][Medline].
42. Sturzenbecker, L. J., M. L. Nibert, D. Furlong, and B. N. Fields. 1987. Intracellular digestion of reovirus particles requires a low pH and is an essential step in the viral infectious cycle. J. Virol. 61:2351-2361[Abstract/Free Full Text].
43. Tyler, K. L., M. K. Squier, S. E. Rodgers, B. E. Schneider, S. M. Oberhaus, T. A. Grdina, J. J. Cohen, and T. S. Dermody. 1995. Differences in the capacity of reovirus strains to induce apoptosis are determined by the viral attachment protein sigma 1. J. Virol. 69:6972-6979[Abstract].
44. Virgin, H. W., IV, R. Bassel-Duby, B. N. Fields, and K. L. Tyler. 1988. Antibody protects against lethal infection with the neurally spreading reovirus type 3 (Dearing). J. Virol. 62:4594-4604[Abstract/Free Full Text].
45. Virgin, H. W., IV, M. A. Mann, B. N. Fields, and K. L. Tyler. 1991. Monoclonal antibodies to reovirus reveal structure/function relationships between capsid proteins and genetics of susceptibility to antibody action. J. Virol. 65:6772-6781[Abstract/Free Full Text].
46. Weiner, H. L., M. L. Powers, and B. N. Fields. 1980. Absolute linkage of virulence and central nervous system cell tropism of reoviruses to viral hemagglutinin. J. Infect. Dis. 141:609-616[Medline].
47. Yeager, M., J. A. Berriman, T. S. Baker, and A. R. Bellamy. 1994. Three-dimensional structure of the rotavirus haemagglutinin VP4 by cryo-electron microscopy and difference map analysis. EMBO J. 13:1011-1018[Medline].
48. Yue, Z., and A. J. Shatkin. 1998. Enzymatic and control functions of reovirus structural proteins. Curr. Top. Microbiol. Immunol. 233:31-56.
49. Zlotnick, A., N. Cheng, J. F. Conway, F. P. Booy, A. C. Steven, S. J. Stahl, and P. T. Wingfield. 1996. Dimorphism of hepatitis B virus capsids is strongly influenced by the C-terminus of the capsid protein. Biochemistry 35:7412-7421[CrossRef][Medline].


Journal of Virology, June 2001, p. 5335-5342, Vol. 75, No. 11
0022-538X/01/$04.00+0   DOI: 10.1128/JVI.75.11.5335-5342.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.



This article has been cited by other articles:

  • Zhang, L., Agosto, M. A., Ivanovic, T., King, D. S., Nibert, M. L., Harrison, S. C. (2009). Requirements for the Formation of Membrane Pores by the Reovirus Myristoylated {micro}1N Peptide. J. Virol. 83: 7004-7014 [Abstract] [Full Text]  
  • Agosto, M. A., Myers, K. S., Ivanovic, T., Nibert, M. L. (2008). A positive-feedback mechanism promotes reovirus particle conversion to the intermediate associated with membrane penetration. Proc. Natl. Acad. Sci. USA 105: 10571-10576 [Abstract] [Full Text]  
  • Agosto, M. A., Middleton, J. K., Freimont, E. C., Yin, J., Nibert, M. L. (2007). Thermolabilizing Pseudoreversions in Reovirus Outer-Capsid Protein {micro}1 Rescue the Entry Defect Conferred by a Thermostabilizing Mutation. J. Virol. 81: 7400-7409 [Abstract] [Full Text]  
  • Zhang, L., Chandran, K., Nibert, M. L., Harrison, S. C. (2006). Reovirus {micro}1 Structural Rearrangements That Mediate Membrane Penetration. J. Virol. 80: 12367-12376 [Abstract] [Full Text]  
  • Trask, S. D., Dormitzer, P. R. (2006). Assembly of Highly Infectious Rotavirus Particles Recoated with Recombinant Outer Capsid Proteins. J. Virol. 80: 11293-11304 [Abstract] [Full Text]  
  • Helander, A., Miller, C. L., Myers, K. S., Neutra, M. R., Nibert, M. L. (2004). Protective Immunoglobulin A and G Antibodies Bind to Overlapping Intersubunit Epitopes in the Head Domain of Type 1 Reovirus Adhesin {sigma}1. J. Virol. 78: 10695-10705 [Abstract] [Full Text]  
  • Odegard, A. L., Chandran, K., Zhang, X., Parker, J. S. L., Baker, T. S., Nibert, M. L. (2004). Putative Autocleavage of Outer Capsid Protein {micro}1, Allowing Release of Myristoylated Peptide {micro}1N during Particle Uncoating, Is Critical for Cell Entry by Reovirus. J. Virol. 78: 8732-8745 [Abstract] [Full Text]  
  • Hutchings, A. B., Helander, A., Silvey, K. J., Chandran, K., Lucas, W. T., Nibert, M. L., Neutra, M. R. (2004). Secretory Immunoglobulin A Antibodies against the {sigma}1 Outer Capsid Protein of Reovirus Type 1 Lang Prevent Infection of Mouse Peyer's Patches. J. Virol. 78: 947-957 [Abstract] [Full Text]  
  • Chandran, K., Parker, J. S. L., Ehrlich, M., Kirchhausen, T., Nibert, M. L. (2003). The {delta} Region of Outer-Capsid Protein {micro}1 Undergoes Conformational Change and Release from Reovirus Particles during Cell Entry. J. Virol. 77: 13361-13375 [Abstract] [Full Text]  
  • Helander, A., Silvey, K. J., Mantis, N. J., Hutchings, A. B., Chandran, K., Lucas, W. T., Nibert, M. L., Neutra, M. R. (2003). The Viral {sigma}1 Protein and Glycoconjugates Containing {alpha}2-3-Linked Sialic Acid Are Involved in Type 1 Reovirus Adherence to M Cell Apical Surfaces. J. Virol. 77: 7964-7977 [Abstract] [Full Text]  
  • Odegard, A. L., Chandran, K., Liemann, S., Harrison, S. C., Nibert, M. L. (2003). Disulfide Bonding among {micro}1 Trimers in Mammalian Reovirus Outer Capsid: a Late and Reversible Step in Virion Morphogenesis. J. Virol. 77: 5389-5400 [Abstract] [Full Text]  
  • Kim, J., Zhang, X., Centonze, V. E., Bowman, V. D., Noble, S., Baker, T. S., Nibert, M. L. (2002). The Hydrophilic Amino-Terminal Arm of Reovirus Core Shell Protein {lambda}1 Is Dispensable for Particle Assembly. J. Virol. 76: 12211-12222 [Abstract] [Full Text]  
  • Middleton, J. K., Severson, T. F., Chandran, K., Gillian, A. L., Yin, J., Nibert, M. L. (2002). Thermostability of Reovirus Disassembly Intermediates (ISVPs) Correlates with Genetic, Biochemical, and Thermodynamic Properties of Major Surface Protein {micro}1. J. Virol. 76: 1051-1061 [Abstract] [Full Text]  

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chandran, K.
Right arrow Articles by Nibert, M. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chandran, K.
Right arrow Articles by Nibert, M. L.